Literature DB >> 15530438

Characterization of the bovine neurofilament NF-M protein and cDNA sequence, and identification of in vitro and in vivo calpain cleavage sites.

Gerry Shaw1, Cui Yang, Lu Zhang, Petra Cook, Brian Pike, William D Hill.   

Abstract

Neurofilaments are the major components of the neuronal cytoskeleton, and accumulations of these proteins are associated with several important human diseases. Here we report the cloning and sequencing of bovine NF-M, the first NF-M cloned from a large domestic mammal. The bovine sequence proves to be generally more similar to that of human NF-M than the previously described mammalian sequences, suggesting that bovine neurofilaments are a useful model for biochemical studies of application to humans. However, we noted some unusual features within the 16 lys-ser-pro (KSP2) type phosphopeptide repeats and also note that the number of these repeats correlates well with the size of animal. We also characterized two in vitro calpain cleavage sites by direct peptide sequencing, finding that both are located in the glutamic acid rich E segment. Finally, we show biochemically that the more abundant and stable of these calpain fragments can also be detected in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530438     DOI: 10.1016/j.bbrc.2004.09.223

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Neurofilaments and Neurofilament Proteins in Health and Disease.

Authors:  Aidong Yuan; Mala V Rao; Ralph A Nixon
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-04-03       Impact factor: 10.005

2.  A novel closed-body model of spinal cord injury caused by high-pressure air blasts produces extensive axonal injury and motor impairments.

Authors:  Nobel del Mar; Xinyu von Buttlar; Angela S Yu; Natalie H Guley; Anton Reiner; Marcia G Honig
Journal:  Exp Neurol       Date:  2015-05-07       Impact factor: 5.330

3.  Generation and Release of Neurogranin, Vimentin, and MBP Proteolytic Peptides, Following Traumatic Brain Injury.

Authors:  George Anis Sarkis; Nicholas Lees-Gayed; Joseph Banoub; Susan E Abbatielo; Claudia Robertson; William E Haskins; Richard A Yost; Kevin K W Wang
Journal:  Mol Neurobiol       Date:  2021-11-11       Impact factor: 5.590

Review 4.  Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.

Authors:  Marek Ma
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

5.  The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury.

Authors:  Kevin J Anderson; Stephen W Scheff; Kelly M Miller; Kelly N Roberts; Lesley K Gilmer; Cui Yang; Gerry Shaw
Journal:  J Neurotrauma       Date:  2008-09       Impact factor: 5.269

Review 6.  Brain injury biomarkers as outcome predictors in pediatric severe traumatic brain injury.

Authors:  Hani Daoud; Ibrahim Alharfi; Ibrahim Alhelali; Tanya Charyk Stewart; Hadiah Qasem; Douglas D Fraser
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

7.  Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis.

Authors:  Melissa M Gresle; Helmut Butzkueven; Gerry Shaw
Journal:  Mult Scler Int       Date:  2011-01-23

8.  Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis.

Authors:  Amena W Smith; Baerbel Rohrer; Lee Wheless; Supriti Samantaray; Swapan K Ray; Jun Inoue; Mitsuyoshi Azuma; Naren L Banik
Journal:  J Neurochem       Date:  2016-09-27       Impact factor: 5.546

9.  Calcium-dependent proteasome activation is required for axonal neurofilament degradation.

Authors:  Joo Youn Park; So Young Jang; Yoon Kyung Shin; Duk Joon Suh; Hwan Tae Park
Journal:  Neural Regen Res       Date:  2013-12-25       Impact factor: 5.135

10.  Calcium influx-mediated translocation of m-calpain induces Ku80 cleavage and enhances the Ku80-related DNA repair pathway.

Authors:  Kyung Hye Baek; Han Vit Yu; Eosu Kim; Younghwa Na; Youngjoo Kwon
Journal:  Oncotarget       Date:  2016-05-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.